Literature DB >> 1282495

Contribution of ICAM-1 and VCAM-1 to the morphological changes in monocytes bound to human venous endothelial cells stimulated with recombinant interleukin-4 (rIL-4) or rIL-1 alpha.

H Beekhuizen1, E M Verdegaal, I Blokland, R van Furth.   

Abstract

The present study focused on the question of whether the expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on the surface of cultured human venous endothelial cells (EC), stimulated with recombinant interleukin-4 (rIL-4) or rIL-1 alpha, contributes to the stretching of human monocytes following their binding to EC. Stimulation of monolayers of venous EC with rIL-4 for 24 hr induced marked expression of VCAM-1 but not ICAM-1 on EC, increased the adhesiveness of EC for monocytes but did not promote stretching of EC-bound monocytes over the surface of EC. Stimulation of EC with rIL-1 alpha for 24 hr induced surface expression of both ICAM-1 and VCAM-1, enhanced the binding of monocytes to EC and increased the percentage of EC-bound monocytes with a stretched morphology about 2.7-fold. Anti-ICAM-1 but not anti-VCAM-1 mAb markedly reduced the percentage stretched monocytes on rIL-1 alpha-stimulated EC. We conclude that ICAM-1 but not VCAM-1 on cytokine-stimulated EC is essential for the stretching of EC-bound monocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282495      PMCID: PMC1421714     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

Review 1.  Selectins: novel receptors that mediate leukocyte adhesion during inflammation.

Authors:  R P McEver
Journal:  Thromb Haemost       Date:  1991-03-04       Impact factor: 5.249

2.  CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells.

Authors:  H Beekhuizen; I Blokland; A J Corsèl-van Tilburg; F Koning; R van Furth
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

Review 3.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells.

Authors:  H Beekhuizen; A J Corsèl-Van Tilburg; I Blokland; R Van Furth
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 5.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.

Authors:  T M Carlos; B R Schwartz; N L Kovach; E Yee; M Rosa; L Osborn; G Chi-Rosso; B Newman; R Lobb; M Rosso
Journal:  Blood       Date:  1990-09-01       Impact factor: 22.113

7.  Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

Authors:  C W Smith; S D Marlin; R Rothlein; C Toman; D C Anderson
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.

Authors:  R Rothlein; M L Dustin; S D Marlin; T A Springer
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils.

Authors:  M H Thornhill; U Kyan-Aung; D O Haskard
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

10.  Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism.

Authors:  G E Rice; J M Munro; M P Bevilacqua
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  9 in total

1.  Intermittent PTH 1-34 administration improves the marrow microenvironment and endothelium-dependent vasodilation in bone arteries of aged rats.

Authors:  Seungyong Lee; Ashley Bice; Brianna Hood; Juan Ruiz; Jahyun Kim; Rhonda D Prisby
Journal:  J Appl Physiol (1985)       Date:  2018-02-08

Review 2.  The adhesion cascade and anti-adhesion therapy: an overview.

Authors:  S R Sharar; R K Winn; J M Harlan
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Endothelial IL-1R1 is a critical mediator of EAE pathogenesis.

Authors:  Qiming Li; Nicole Powell; Hao Zhang; Natalya Belevych; San Ching; Qun Chen; John Sheridan; Caroline Whitacre; Ning Quan
Journal:  Brain Behav Immun       Date:  2010-09-18       Impact factor: 7.217

Review 4.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

5.  Surface molecules involved in the adherence of recombinant interferon-gamma (rIFN-gamma)-stimulated human monocytes to vascular endothelial cells.

Authors:  J Wang; H Beekhuizen; R van Furth
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  Hemodynamic modulation of monocytic cell adherence to vascular endothelium.

Authors:  R S Gonzales; T M Wick
Journal:  Ann Biomed Eng       Date:  1996 May-Jun       Impact factor: 3.934

7.  Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells.

Authors:  M F Iademarco; J L Barks; D C Dean
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 8.  Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function.

Authors:  Yu Ding; Yongwen Zhou; Ping Ling; Xiaojun Feng; Sihui Luo; Xueying Zheng; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Theranostics       Date:  2021-09-09       Impact factor: 11.556

9.  IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling.

Authors:  Tom Skaria; Julia Burgener; Esther Bachli; Gabriele Schoedon
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.